Qiming-backed genomic testing firm Berry Oncology closes over $99m Series B1 round

Qiming-backed genomic testing firm Berry Oncology closes over $99m Series B1 round

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter